Advertisement

Topics

Search Results for "Mylan Atovaquone And Proguanil 250mg 100mg Tablet"

18:33 EDT 1st October 2016 | BioPortfolio

Matching Channels

Selective monoamine oxidase type B MAOB inhibitors

The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...

Matching News

Molecular features of biguanides required for targeting of mitochondrial respiratory complex

The biguanides are a family of drugs with diverse clinical applications. Metformin, a widely used anti-hyperglycemic biguanide, suppresses mitochondrial respiration by inhibiting respiratory complex I...

Resistance to antimalarial atovaquone does not spread

Atovaquone could be used more widely to treat malaria since resistance does not spread to subsequent generations of the malaria parasite.

Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase

The biguanides are a family of drugs with diverse clinical applications. Metformin, a widely used anti-hyperglycemic biguanide, suppresses mitochondrial respiration by inhibiting respiratory complex I...

Australian researchers confirm Atovaquone's ability to combat malaria parasite

Researchers at the University of Melbourne, Australia, have discovered that an anti-malarial drug called Atovaquone, which was thought to be ineffective, has the ability to combat the malaria parasite...

Mutant malaria parasites resistant to antimalarial Atovaquone cannot spread: new research

By Prodita Sabarini, The Conversation Resistance to a commonly used antimalarial medication, Atovaquone, can’t spread to the general human population, new research suggests. This is significant as s...

Mylan: Alles in Butter?

Mylan ist der weltweit drittgrößte Generika-Hersteller und entwickelt über seine Tochtergesellschaften Mylan Pharmaceuticals, UDL Laboratories, Matrix Labs, Bertek Pharmaceuticals und Mylan Tech ve...

No One Is More Frustrated About EpiPen Pricing than Mylan's CEO, Says Mylan's CEO

When you have a disease that you can’t cure, the next best thing is to treat the symptoms. Mylan is a symptom.

Schadenfreude Aside, Mylan Is Now Takeover Bait With A Possible 50% Return

Teva failed in its attempt to acquire Mylan last year. Mylan's reduced market capitalization could whet its appetite once again.

Matching PubMed Articles

Exploration of the associations of touch-screen tablet computer usage and musculoskeletal discomfort.

Tablet users may be at high risk of developing physical discomfort because of their usage behaviors and tablet design.

Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management.

Simplification of antiretroviral therapy enhances a patient's adherence but a new formulation could also lead to new adverse events and changes in daily routine. This study compared medication adheren...

Microstructure of Tablet-Pharmaceutical Significance, Assessment, and Engineering.

To summarize the microstructure - property relationship of pharmaceutical tablets and approaches to improve tablet properties through tablet microstructure engineering.

MANIPULATION OF RUMEN MICROBIAL FERMENTATION BY POLYPHENOL RICH SOLVENT FRACTIONS FROM PAPAYA LEAF TO REDUCE GREEN-HOUSE GAS METHANE AND BIOHYDROGENATION OF C18 PUFA.

Different solvents (hexane, chloroform, ethyl acetate, butanol and water, respectively) were used to identify the effect of PL fractions (PLFs) on ruminal biohydrogenation (BH) and ruminal methanogene...

Transforming the Classroom With Tablet Technology.

Identifying the most effective models for integrating new technology into the classroom and understanding its effects on educational outcomes are essential for nurse educators. This article describes ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement